While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...

德国制药巨头默克公司（Merck KGaA）确认，正在就收购美国生物制药公司SpringWorks Therapeutics进行深入谈判，后者是一家专门研究罕见疾病和癌症的公司。

SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even ...

Ahead of Merck KGaA’s earnings announcement Thursday, investors were mostly looking forward to any comments about its ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

Elon Musk Leads $97.4 Billion Bid to Acquire OpenAI, Sam Altman Claps Back With ‘No Thanks’ Burn on X Mark Cuban's $400K Bet On Teen Founder Comes With An Unexpected Invitation: 'I Want My ...

Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks about a possible takeover, a new FDA approval could have sweetened the deal. Stamford, Connecticut-based SpringWorks ...

Germany's Merck KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer.

Idrees Abbas / SOPA Images / LightRocket / Getty Images Shares of SpringWorks Therapeutics soared on Monday following a report that German medical firm Merck KGaA could acquire the company.

Barclays analyst Peter Lawson says SpringWorks Therapeutics (SWTX) this morning cancelled from the firm’s conference next week, following ...